Literature DB >> 10704358

U94, the human herpesvirus 6 homolog of the parvovirus nonstructural gene, is highly conserved among isolates and is expressed at low mRNA levels as a spliced transcript.

J C Rapp1, L T Krug, N Inoue, T R Dambaugh, P E Pellett.   

Abstract

Human herpesvirus 6 variants A and B (HHV-6A and HHV-6B, respectively) encode homologs (U94) of the parvovirus nonstructural gene, ns1 or rep. Here we describe the HHV-6B homolog and analyze its genetic heterogeneity and transcription. U94 nucleotide and amino acid sequences differ by approximately 3.5% and 2.5%, respectively, between HHV-6A and HHV-6B. Among a collection of 17 clinically and geographically disparate HHV-6 isolates, intravariant nucleotide and amino acid sequence divergence was less than 0.6% and 0.2%, respectively; all 13 HHV-6B isolates had identical amino acid sequences. The U94 transcript is spliced to remove a 2.6-kb intron and is expressed at very low levels relative to other HHV-6B genes, reaching approximately 10 copies per cell 3 days after infection. The mRNA has several small AUG-initiated open reading frames upstream of the U94 open reading frame, a hallmark of proteins expressed at low levels. Consistent with this, the U94-encoded protein was immunologically undetectable in HHV-6B-infected cells. The high degree of sequence conservation suggests that the gene function is nearly intolerant of sequence variation. The low abundance of U94 transcripts and the presence of encoded inefficient translation initiation suggest that the U94 protein may be required only in small amounts during infection. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704358     DOI: 10.1006/viro.1999.0163

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Identification of human herpesvirus 6 latency-associated transcripts.

Authors:  Kazuhiro Kondo; Kazuya Shimada; Junji Sashihara; Keiko Tanaka-Taya; Koichi Yamanishi
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Viral gene expression patterns in human herpesvirus 6B-infected T cells.

Authors:  Bodil Øster; Per Höllsberg
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

3.  Detection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis.

Authors:  Elisabetta Caselli; Michela Boni; Arianna Bracci; Antonella Rotola; Claudio Cermelli; Massimiliano Castellazzi; Dario Di Luca; Enzo Cassai
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 4.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Molecular phenotypes of human parvovirus B19 in patients with myocarditis.

Authors:  C-Thomas Bock; Anja Düchting; Friederike Utta; Eva Brunner; Bui Tien Sy; Karin Klingel; Florian Lang; Meinrad Gawaz; Stephan B Felix; Reinhard Kandolf
Journal:  World J Cardiol       Date:  2014-04-26

Review 6.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 7.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574

8.  U94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesis.

Authors:  Arnaldo Caruso; Elisabetta Caselli; Simona Fiorentini; Antonella Rotola; Alberto Prandini; Emirena Garrafa; Elisa Saba; Giulio Alessandri; Enzo Cassai; Dario Di Luca
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

9.  Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis.

Authors:  Elisabetta Caselli; Maria Chiara Zatelli; Roberta Rizzo; Sabrina Benedetti; Debora Martorelli; Giorgio Trasforini; Enzo Cassai; Ettore C degli Uberti; Dario Di Luca; Riccardo Dolcetti
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

Review 10.  Viral Proteins as Emerging Cancer Therapeutics.

Authors:  Ekta Manocha; Arnaldo Caruso; Francesca Caccuri
Journal:  Cancers (Basel)       Date:  2021-05-03       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.